CB Therapeutics GTM brain

category

market profile

• text: The platform combines microbial production of scarce natural compounds with AI-assisted design and laboratory screening of new therapeutic candidates.
• text: Potential applications include longevity research, mental health research and compounds for medicines and wellness products.

personas

• title: Biotech discovery or medicinal chemistry leader
  pains:

  • Obtain sufficient quantities of scarce natural molecules for research
  • Screen and refine candidate molecules against a new therapeutic target
• title: Head of ingredient sourcing at a wellness brand
  pains:

  • Secure reproducible supply of high-value ingredients that are difficult to extract from plants
  • Assess purity, scale and commercial viability before product development
• title: Bioprocess development director
  pains:

  • Move an engineered strain from lab experiments toward pilot scale
  • Coordinate fermentation and downstream analysis while controlling variability

icp

• text: Biotech and pharmaceutical research teams investigating peptides, alkaloids, cannabinoids or other scarce natural molecules.
• text: Wellness and supplement product developers looking for ingredients produced through microbial fermentation.
• text: Research and commercial partners with a defined molecule or target and resources to evaluate technical feasibility and supply requirements; company size is not publicly specified.

message pillars

• text: Combine biological engineering with computational design.
• text: Use fermentation to make natural products available reproducibly.
• text: Connect molecule design to testing and pilot-scale infrastructure.

objections

• objection: Can fermentation produce our target at the required purity and yield?
  response: Ask for compound-specific analytical data, strain feasibility and a defined pilot before making a supply commitment.
• objection: AI-generated candidates may not translate into usable molecules.
  response: Discuss the wet-lab testing and analytical feedback loop, and evaluate results for the particular target.
• objection: Can this meet our clinical or commercial regulatory requirements?
  response: Request documentation and qualification for the intended use; the website does not establish approval for every compound.

competitors

• name: Ginkgo Bioworks
  why: Offers organism engineering and biomanufacturing development services.
• name: Brightseed
  why: Uses computational discovery for bioactive compounds and health ingredients.

influencers

• name: Jacob Vogan
  url: https://www.syntheticbiologysummit.com/2025/event-speaker/jacob-vogan
  why: Co-founder and scientific leader speaking publicly on synthetic biology and therapeutic compounds.

keywords

• precision fermentation natural ingredients
• biosynthetic cannabinoid production
• fermentation derived natural compounds
• synthetic biology ingredient development
• AI peptide discovery
• microbial strain engineering

voice

• scientific
• optimistic
• explanatory

signals

• text: A drug discovery program seeks a reliable source of a scarce plant-derived research compound.
• text: A wellness ingredient company explores fermentation or launches a new natural compound program.

stack

• engineered yeast
• LC-MS
• HPLC
• GC

pricing

motion

channels

• website
• LinkedIn
• scientific conferences

confidence

Founders

• name: Sher Butt
  title: Founder/CEO
  role: CEO
• name: Jacob Vogan
  title: Founder
  role: Founder
  bio: Co-founded CB Therapeutics to create new biological supply chains for rare natural products that can help treat disease, increase healthspan, and promote longevity.